Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis

Nature Chemical Biology
2009.0

Abstract

The recent discovery of fatty acyl-AMP ligases (FAALs) in Mycobacterium tuberculosis (Mtb) provided a new perspective of fatty acid activation. These proteins convert fatty acids to the corresponding adenylates, which are intermediates of acyl-CoA-synthesizing fatty acyl-CoA ligases (FACLs). Presently, it is not evident how obligate pathogens such as Mtb have evolved such new themes of functional versatility and whether the activation of fatty acids to acyladenylates could indeed be a general mechanism. Here, based on elucidation of the first structure of an FAAL protein and by generating loss-of-function and gain-of-function mutants that interconvert FAAL and FACL activities, we demonstrate that an insertion motif dictates formation of acyladenylate. Because FAALs in Mtb are crucial nodes in the biosynthetic network of virulent lipids, inhibitors directed against these proteins provide a unique multipronged approach to simultaneously disrupting several pathways.

Knowledge Graph

Similar Paper

Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis
Nature Chemical Biology 2009.0
Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis
European Journal of Medicinal Chemistry 2020.0
Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening
European Journal of Medicinal Chemistry 2020.0
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis
Bioorganic & Medicinal Chemistry 2022.0
Fatty Acyl‐AMP Ligase Involvement in the Production of Alkylresorcylic Acid by a <i>Myxococcus xanthus</i> Type III Polyketide Synthase
ChemBioChem 2011.0
An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors
European Journal of Medicinal Chemistry 2018.0
Synthesis and antituberculosis activity of new fatty acid amides
Bioorganic &amp; Medicinal Chemistry Letters 2010.0
Rationally Designed Nucleoside Antibiotics That Inhibit Siderophore Biosynthesis of Mycobacterium tuberculosis
Journal of Medicinal Chemistry 2006.0
Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
Journal of Medicinal Chemistry 2006.0
Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2011.0